A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department
Clinical trial NCT02584660 · COMPLETED
Trial details
- NCT number
- NCT02584660
- Sponsor
- Janssen Scientific Affairs, LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-15
- Primary completion
- 2017-03-22
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.